Varex Imaging Corporation (VREX) Q3 2025 Earnings Call Transcript

Varex Imaging Corporation (VREX) reported Q3 FY2025 revenue of $203 million, exceeding guidance, with non-GAAP gross margin of 34% and non-GAAP EPS of $0.18. While overall revenue declined 3% year-over-year, the Industrial segment grew 1% driven by strong security screening demand and over $55 million in year-to-date cargo system bookings, while China sales stabilized after tariff reductions. The company posted a GAAP net loss of $89 million, or $2.15 per share, primarily due to a $94 million non-cash goodwill impairment charge. Varex also repaid $200 million in convertible notes, strengthening its capital structure. Looking ahead, Varex projects Q4 revenue of $210-$230 million and non-GAAP EPS of $0.10-$0.30, expecting continued growth into fiscal year 2026 despite anticipated gross margin pressures from tariffs and product mix.

Analysis

Varex Imaging Corporation reported robust Q3 fiscal 2025 results, with revenue of $203 million and non-GAAP EPS of $0.18 both surpassing the high end of guidance. The performance was underpinned by continued strength in the Industrial segment, which grew 1% year-over-year, driven by strong demand for security and cargo inspection systems, evidenced by over $55 million in year-to-date bookings. A critical development was the stabilization of the China business, which accounted for 15% of revenue; after an initial pause due to prohibitive 145% tariffs, shipments resumed as expected when tariffs fell to 55%, illustrating both operational agility and geopolitical risk exposure. Despite a 4% revenue decline in the Medical segment, non-GAAP gross margin expanded 100 basis points to 34% on favorable product mix. However, the company recorded a significant GAAP net loss of $89 million, or $2.15 per share, primarily due to a $94 million non-cash goodwill impairment charge stemming from a decline in the company's market capitalization. On the balance sheet, Varex strengthened its capital structure by repaying a $200 million convertible note, bringing its net debt leverage ratio to approximately 2x adjusted EBITDA. The outlook for Q4 is strong with revenue guided to $210-$230 million, though projected non-GAAP gross margins are expected to contract sequentially to 32-33% due to product mix and ongoing tariff pressures.

Key Decisions for Investors

• Investors should recognize the strong operational performance and balance sheet deleveraging, but must closely monitor the Q4 guided gross margin compression to 32-33%, attributed to product mix and tariff impacts, to assess the long-term profitability trajectory.
• The significant $94 million non-cash goodwill impairment charge, driven by a decline in market capitalization, warrants scrutiny as a key risk factor reflecting the market's perception of long-term value despite positive non-GAAP results.
• Focus should be placed on the Industrial segment's execution of its robust cargo systems backlog, which represents the primary near-term growth catalyst, while tracking the progress of longer-term initiatives like photon counting and the India manufacturing ramp-up.
• Given that China constitutes 15% of revenue, investors should factor in the potential for renewed trade policy volatility, as the environment remains fluid despite the recent stabilization of shipments and demand.